The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?

Trends in Neurosciences

Volumn 31, Issue 5, 2008, Pages 251-256

  Fukui, Hirokazu ^a   Moraes, Carlos T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; CITRIC ACID CYCLE; CYTOCHROME C OXIDASE DEFICIENCY; DEGENERATIVE DISEASE; ENZYME INHIBITION; FEEDBACK SYSTEM; GENE MUTATION; HUMAN; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

AGING; ALZHEIMER DISEASE; ANIMALS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MITOCHONDRIA; MUTATION; NERVE DEGENERATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES;

EID: 42749087763     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2008.02.008     Document Type: Review

References (69)

1. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
2. Balaban R.S., et al. Mitochondria, oxidants, and aging. Cell 120 (2005) 483-495
3. Veal E.A., et al. Hydrogen peroxide sensing and signaling. Mol. Cell 26 (2007) 1-14
4. Giorgio M., et al. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?. Nat. Rev. Mol. Cell Biol. 8 (2007) 722-728
5. Bandy B., and Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?. Free Radic. Biol. Med. 8 (1990) 523-539
6. Taylor R.W., and Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 6 (2005) 389-402
7. Kujoth G.C., et al. The role of mitochondrial DNA mutations in mammalian aging. PLoS Genet. 3 (2007) e24
8. Kraytsberg Y., et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38 (2006) 518-520
9. Bender A., et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38 (2006) 515-517
10. Lezza A.M., et al. Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients. FASEB J. 13 (1999) 1083-1088
11. Mawrin C., et al. Region-specific analysis of mitochondrial DNA deletions in neurodegenerative disorders in humans. Neurosci. Lett. 357 (2004) 111-114
12. Kujoth G.C., et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309 (2005) 481-484
13. Trifunovic A., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429 (2004) 417-423
14. Trifunovic A., et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17993-17998
15. Hiona A., and Leeuwenburgh C. The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp. Gerontol. 43 (2008) 24-33
16. Mattson M.P., and Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7 (2006) 278-294
17. Srivastava S., and Moraes C.T. Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans. Hum. Mol. Genet. 14 (2005) 893-902
18. Wanrooij S., et al. Expression of catalytic mutants of the mtDNA helicase Twinkle and polymerase POLG causes distinct replication stalling phenotypes. Nucleic Acids Res. 35 (2007) 3238-3251
19. Lieber M.R., and Karanjawala Z.E. Ageing, repetitive genomes and DNA damage. Nat. Rev. Mol. Cell Biol. 5 (2004) 69-75
20. Sazanov L.A. Respiratory complex I: mechanistic and structural insights provided by the crystal structure of the hydrophilic domain. Biochemistry 46 (2007) 2275-2288
21. Lenaz G., et al. Mitochondrial complex I: structural and functional aspects. Biochim. Biophys. Acta 1757 (2006) 1406-1420
22. Thomas B., and Beal M.F. Parkinson's disease. Hum. Mol. Genet. 16 R2 (2007) R183-R194
23. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
24. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
25. Sherer T.B., et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J. Neurochem. 100 (2007) 1469-1479
26. Liang L.P., et al. An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo. J. Neurosci. 27 (2007) 4326-4333
27. Yadava N., and Nicholls D.G. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J. Neurosci. 27 (2007) 7310-7317
28. Hung A.Y., and Schwarzschild M.A. Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?. Curr. Opin. Neurol. 20 (2007) 477-483
29. Storch A., et al. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch. Neurol. 64 (2007) 938-944
30. St-Pierre J., et al. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277 (2002) 44784-44790
31. Gyulkhandanyan A.V., and Pennefather P.S. Shift in the localization of sites of hydrogen peroxide production in brain mitochondria by mitochondrial stress. J. Neurochem. 90 (2004) 405-421
32. + oxidation-reduction state. Biochem. J. 368 (2002) 545-553
33. Iuso A., et al. Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J. Biol. Chem. 281 (2006) 10374-10380
34. Gu M., et al. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann. Neurol. 44 (1998) 177-186
35. Swerdlow R.H., et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40 (1996) 663-671
36. Aomi Y., et al. Cytoplasmic transfer of platelet mtDNA from elderly patients with Parkinson's disease to mtDNA-less HeLa cells restores complete mitochondrial respiratory function. Biochem. Biophys. Res. Commun. 280 (2001) 265-273
37. Vives-Bauza C., et al. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem. Biophys. Res. Commun. 290 (2002) 1593-1601
38. Simon D.K., et al. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 25 (2004) 71-81
39. Parker Jr. W.D., and Parks J.K. Mitochondrial ND5 mutations in idiopathic Parkinson's disease. Biochem. Biophys. Res. Commun. 326 (2005) 667-669
40. Smigrodzki R., et al. High frequency of mitochondrial complex I mutations in Parkinson's disease and aging. Neurobiol. Aging 25 (2004) 1273-1281
41. van der Walt J.M., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72 (2003) 804-811
42. Hattori N., et al. Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics 49 (1998) 52-58
43. Zweig R.M., et al. The familial occurrence of Parkinson's disease. Lack of evidence for maternal inheritance. Arch. Neurol. 49 (1992) 1205-1207
44. Fontanesi F., et al. Assembly of mitochondrial cytochrome c-oxidase, a complicated and highly regulated cellular process. Am. J. Physiol. Cell Physiol. 291 (2006) C1129-C1147
45. Moraes C.T., et al. Defects in the biosynthesis of mitochondrial heme c and heme a in yeast and mammals. Biochim. Biophys. Acta 1659 (2004) 153-159
46. Diaz F., et al. Cytochrome c oxidase is required for the assembly/stability of respiratory complex I in mouse fibroblasts. Mol. Cell. Biol. 26 (2006) 4872-4881
47. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552 (2003) 335-344
48. Prabhakaran K., et al. Cyanide induces different modes of death in cortical and mesencephalon cells. J. Pharmacol. Exp. Ther. 303 (2002) 510-519
49. Jacobson J., et al. Induction of mitochondrial oxidative stress in astrocytes by nitric oxide precedes disruption of energy metabolism. J. Neurochem. 95 (2005) 388-395
50. Takuma K., et al. ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction. FASEB J. 19 (2005) 597-598
51. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
52. Oddo S., et al. Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease. A link between Aβ and tau pathology. J. Biol. Chem. 281 (2006) 1599-1604
53. Fukui H., et al. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14163-14168
54. Tamagno E., et al. Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J. Neurochem. 104 (2008) 683-695
55. Tamagno E., et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10 (2002) 279-288
56. Fukumoto H., et al. β-Secretase activity increases with aging in human, monkey, and mouse brain. Am. J. Pathol. 164 (2004) 719-725
57. Tong Y., et al. Oxidative stress potentiates BACE1 gene expression and Aβ generation. J. Neural Transm. 112 (2005) 455-469
58. Melov S., et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2 (2007) e536
59. Dell'agnello C., et al. Increased longevity and refractoriness to Ca(2+)-dependent neurodegeneration in Surf1 knockout mice. Hum. Mol. Genet. 16 (2007) 431-444
60. Barja G. Free radicals and aging. Trends Neurosci. 27 (2004) 595-600
61. Schriner S.E., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909-1911
62. St-Pierre J., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127 (2006) 397-408
63. Wang H., et al. Over-expression of antioxidant enzymes protects cultured hippocampal and cortical neurons from necrotic insults. J. Neurochem. 87 (2003) 1527-1534
64. Elson J.L., et al. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease?. Hum. Genet. 119 (2006) 241-254
65. Lin M.T., et al. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11 (2002) 133-145
66. Devi L., et al. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26 (2006) 9057-9068
67. Atamna H. Heme binding to amyloid-β peptide: mechanistic role in Alzheimer's disease. J. Alzheimers Dis. 10 (2006) 255-266
68. Atamna H., and Frey II W.H. A role for heme in Alzheimer's disease: heme binds amyloid β and has altered metabolism. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11153-11158
69. Lustbader J.W., et al. ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452